Advertisement

European Journal of Nutrition

, Volume 51, Issue 4, pp 465–476 | Cite as

CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract

  • Carlota Oleaga
  • Miriam García
  • Anna Solé
  • Carlos J. Ciudad
  • Maria Izquierdo-Pulido
  • Véronique NoéEmail author
Original Contribution

Abstract

Purpose

To evaluate the effect of cocoa flavonoids in breast cancer cells at the molecular level, a functional genomic analysis was performed using a polyphenolic cocoa extract (PCE) in MCF-7 and SKBR3 cell lines.

Methods

The expression profile of 84 genes included in the Stress & Toxicity PathwayFinder™ PCR Array was analyzed after PCE incubation for 24 h. mRNA and protein levels were analyzed by RT-PCR and western blot, respectively. Gel shift assays were used to evaluate DNA–protein complexes. Protein complexes were identified by co-immunoprecipitation. Cell viability was evaluated by MTT assays.

Results

Upon PCE incubation, 7 genes were overexpressed and 1 underexpressed in MCF-7 cells, whereas 9 genes were overexpressed in SKBR3 cells. Among the differentially expressed genes in both cell lines, cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) was chosen for further study. CYP1A1 mRNA and protein levels and enzymatic activity increased upon PCE incubation. CYP1A1 transcriptional activation by PCE was mediated through AhR binding to XRE elements within the CYP1A1 promoter in MCF-7 cells. A protein complex including AhR and ERα was detected. The combination of PCE with tamoxifen caused a synergistic cytotoxicity in both cell lines and was due to an increase in apoptosis in MCF-7 cells.

Conclusions

The interaction between ERα and AhR upon incubation with PCE leads to CYP1A1 induction in breast cancer cells. The synergy between PCE and non-cytotoxic tamoxifen concentrations opens the possibility for a combination therapy based on polyphenols from cocoa that increased tamoxifen efficacy.

Keywords

AhR Cocoa CYP1A1 ERα Tamoxifen Breast cancer 

Abbreviations

AhR

Aryl hydrocarbon receptor,

Arnt

Aryl hydrocarbon receptor nuclear translocator

BSA

Bovine serum albumin

CHX

Cycloheximide

CI

Combination index

CYP1A1

Cytochrome P450 family 1 subfamily A polypeptide 1

DEPC

Diethyl pyrocarbonate

EGCG

Epigallocatechin-3-gallate

EMSA

Electrophoretic mobility shift assay

ER

Estrogen receptor

GS

Gel shift

NE

Nuclear extract

OVN

Overnight

PCE

Polyphenolic cocoa extract

PI

Propidium iodide

RT-PCR

Reverse transcription-polymerase chain reaction

SE

Standard error

STP

Staurosporine

TAM

Tamoxifen

XRE

Xenobiotic response element

Notes

Acknowledgments

This work was supported by grants by Nutrexpa SA (CDTI 050618), SAF08-0043 (Ministerio de Educación y Ciencia de España), and ISCIII-RTICc RD06/0020 (Redes Temáticas de Investigación Cooperativa en Salud) RD06/0020/0046. Our research group holds the “quality distinction” from the “Generalitat de Catalunya” SGR2009-00118. CO. was a recipient of a fellowship from the FEC (Federación Española del Café). The authors wish to thank to Dr. Lamuela-Raventós for the analysis of the polyphenol contents in the cocoa samples and Dr. Cascante for her help in the analyses of synergism by statistical methods.

Author disclosure

C. Oleaga, M. García, A. Solé, C.J. Ciudad, M. Izquierdo-Pulido, and V. Noé have no conflicts of interest.

Supplementary material

394_2011_231_MOESM1_ESM.pdf (309 kb)
Supplementary material 1 (PDF 309 kb)

References

  1. 1.
    Ferlay J, Bray F, Pisani P et al (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, Version 2.0. International Agency for Research on Cancer, LyonGoogle Scholar
  2. 2.
    Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592CrossRefGoogle Scholar
  3. 3.
    Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344:276–285CrossRefGoogle Scholar
  4. 4.
    Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616CrossRefGoogle Scholar
  5. 5.
    Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 100:3913–3918CrossRefGoogle Scholar
  6. 6.
    Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270–282CrossRefGoogle Scholar
  7. 7.
    Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766:63–78Google Scholar
  8. 8.
    Cavalieri EL, Rogan EG (2004) A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci 1028:247–257CrossRefGoogle Scholar
  9. 9.
    Patel MM, Bhat HK (2004) Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: involvement of metabolic activation and cytochrome P450. J Biochem Mol Toxicol 18:37–42CrossRefGoogle Scholar
  10. 10.
    Dhingra K (1999) Antiestrogens–tamoxifen, SERMs and beyond. Invest New Drugs 17:285–311CrossRefGoogle Scholar
  11. 11.
    Rutqvist LE, Cedermark B, Fornander T, Glas U, Johansson H, Nordenskjold B, Rotstein S, Skoog L, Somell A, Theve T (1989) The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer. J Clin Oncol 7:1474–1484Google Scholar
  12. 12.
    Port ER, Montgomery LL, Heerdt AS, Borgen PI (2001) Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol 7:580–585CrossRefGoogle Scholar
  13. 13.
    Ahmad N, Mukhtar H (1999) Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 57:78–83CrossRefGoogle Scholar
  14. 14.
    Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, Sonenshein GE (2001) Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 82:387–398CrossRefGoogle Scholar
  15. 15.
    Vergote D, Cren-Olive C, Chopin V, Toillon RA, Rolando C, Hondermarck H, Le Bourhis X (2002) (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Res Treat 76:195–201CrossRefGoogle Scholar
  16. 16.
    Gupta S, Ahmad N, Nieminen AL, Mukhtar H (2000) Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 164:82–90CrossRefGoogle Scholar
  17. 17.
    Lee KW, Kim YJ, Lee HJ, Lee CY (2003) Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem 51:7292–7295CrossRefGoogle Scholar
  18. 18.
    Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103:1024–1029CrossRefGoogle Scholar
  19. 19.
    Cooper KA, Donovan JL, Waterhouse AL, Williamson G (2008) Cocoa and health: a decade of research. Br J Nutr 99:1–11CrossRefGoogle Scholar
  20. 20.
    Corti R, Flammer AJ, Hollenberg NK, Luscher TF (2009) Cocoa and cardiovascular health. Circulation 119:1433–1441CrossRefGoogle Scholar
  21. 21.
    Visioli F, Bernaert H, Corti R, Ferri C, Heptinstall S, Molinari E, Poli A, Serafini M, Smit HJ, Vinson JA, Violi F, Paoletti R (2009) Chocolate, lifestyle, and health. Crit Rev Food Sci Nutr 49:299–312CrossRefGoogle Scholar
  22. 22.
    Andrés-Lacueva C, Lamuela-Raventós RM, Jauregui O, Casals I, Izquierdo-Pulido M, Permanyer J (2000) An LC method for the analysis of cocoa phenolics. LCoGC Eur 13:902–904Google Scholar
  23. 23.
    Swain T, Hillis WE (1969) The total phenolic constituents of Prunus domestica. J Sci Food Agric 10:4292–4296Google Scholar
  24. 24.
    Selga E, Morales C, Noe V, Peinado MA, Ciudad CJ (2008) Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells. BMC Med Genomics 1:35CrossRefGoogle Scholar
  25. 25.
    Selga E, Oleaga C, Ramirez S, de Almagro MC, Noe V, Ciudad CJ (2009) Networking of differentially expressed genes in human cancer cells resistant to methotrexate. Genome Med 1:83CrossRefGoogle Scholar
  26. 26.
    Tapias A, Ciudad CJ, Noe V (2008) Transcriptional regulation of the 5′-flanking region of the human transcription factor Sp3 gene by NF-1, c-Myb, B-Myb, AP-1 and E2F. Biochim Biophys Acta 1779:318–329Google Scholar
  27. 27.
    Noe V, Alemany C, Chasin LA, Ciudad CJ (1998) Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter. Oncogene 16:1931–1938CrossRefGoogle Scholar
  28. 28.
    Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefGoogle Scholar
  29. 29.
    Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–681CrossRefGoogle Scholar
  30. 30.
    Blasco F, Penuelas S, Cascallo M, Hernandez JL, Alemany C, Masa M, Calbo J, Soler M, Nicolas M, Perez-Torras S, Gomez A, Tarrason G, Noe V, Mazo A, Ciudad CJ, Piulats J (2004) Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy. Oncology 67:277–290CrossRefGoogle Scholar
  31. 31.
    Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59:65–85CrossRefGoogle Scholar
  32. 32.
    Ciolino HP, Daschner PJ, Yeh GC (1999) Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 340(Pt 3):715–722CrossRefGoogle Scholar
  33. 33.
    Trapani V, Patel V, Leong CO, Ciolino HP, Yeh GC, Hose C, Trepel JB, Stevens MF, Sausville EA, Loaiza-Perez AI (2003) DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br J Cancer 88:599–605CrossRefGoogle Scholar
  34. 34.
    Chisholm K, Bray BJ, Rosengren RJ (2004) Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 15:889–897CrossRefGoogle Scholar
  35. 35.
    Scandlyn MJ, Stuart EC, Somers-Edgar TJ, Menzies AR, Rosengren RJ (2008) A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. Br J Cancer 99:1056–1063CrossRefGoogle Scholar
  36. 36.
    Stuart EC, Larsen L, Rosengren RJ (2007) Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells. Int J Oncol 30:1407–1412Google Scholar
  37. 37.
    Nebert DW, Dalton TP, Okey AB, Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847–23850CrossRefGoogle Scholar
  38. 38.
    Parl FF, Dawling S, Roodi N, Crooke PS (2009) Estrogen metabolism and breast cancer: a risk model. Ann N Y Acad Sci 1155:68–75CrossRefGoogle Scholar
  39. 39.
    Huang Z, Fasco MJ, Figge HL, Keyomarsi K, Kaminsky LS (1996) Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab Dispos 24:899–905Google Scholar
  40. 40.
    Delescluse C, Lemaire G, de Sousa G, Rahmani R (2000) Is CYP1A1 induction always related to AHR signaling pathway? Toxicology 153:73–82CrossRefGoogle Scholar
  41. 41.
    Okey AB, Riddick DS, Harper PA (1994) Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol Sci 15:226–232CrossRefGoogle Scholar
  42. 42.
    Ramadass P, Meerarani P, Toborek M, Robertson LW, Hennig B (2003) Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol Sci 76:212–219CrossRefGoogle Scholar
  43. 43.
    Wijayaratne AL, McDonnell DP (2001) The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276:35684–35692CrossRefGoogle Scholar
  44. 44.
    Balan KV, Wang Y, Chen SW, Pantazis P, Wyche JH, Han Z (2006) Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition. Biochem Pharmacol 72:566–572CrossRefGoogle Scholar
  45. 45.
    Alarid ET, Bakopoulos N, Solodin N (1999) Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522–1534CrossRefGoogle Scholar
  46. 46.
    Yu KD, Di GH, Li WF, Rao NY, Fan L, Yuan WT, Hu Z, Wu J, Shen ZZ, Huang W, Shao ZM (2010) Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations. Breast Cancer Res Treat 121:157–167CrossRefGoogle Scholar
  47. 47.
    Yoshida T, Maeda A, Horinaka M, Shiraishi T, Nakata S, Wakada M, Yogosawa S, Sakai T (2005) Quercetin induces gadd45 expression through a p53-independent pathway. Oncol Rep 14:1299–1303Google Scholar
  48. 48.
    Suganuma M, Saha A, Fujiki H (2011) New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102:317–323CrossRefGoogle Scholar
  49. 49.
    Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, Metz J, Kinscherf R (2004) Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 318:325–333CrossRefGoogle Scholar
  50. 50.
    Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, Bentrem DJ, Talamonti MS, Bell RH, Adrian TE (2007) Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res 138:163–169CrossRefGoogle Scholar
  51. 51.
    Lim JH, Park JW, Min DS, Chang JS, Lee YH, Park YB, Choi KS, Kwon TK (2007) NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 12:411–421CrossRefGoogle Scholar
  52. 52.
    Comitato R, Leoni G, Canali R, Ambra R, Nesaretnam K, Virgili F (2010) Tocotrienols activity in MCF-7 breast cancer cells: involvement of ERbeta signal transduction. Mol Nutr Food Res 54:669–678CrossRefGoogle Scholar
  53. 53.
    Katz DL, Doughty K, Ali A (2011) Cocoa and chocolate in human health and disease. Antioxid Redox Signal. doi: 10.1089/ars.2010.3697
  54. 54.
    Balliet AG, Hollander MC, Fornace AJ Jr, Hoffman B, Liebermann DA (2003) Comparative analysis of the genetic structure and chromosomal mapping of the murine Gadd45g/CR6 gene. DNA Cell Biol 22:457–468CrossRefGoogle Scholar
  55. 55.
    Fletcher N, Wahlstrom D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K, Hellmold H, Hakansson H (2005) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol Appl Pharmacol 207:1–24CrossRefGoogle Scholar
  56. 56.
    Ferlini C, Scambia G, Distefano M, Filippini P, Isola G, Riva A, Bombardelli E, Fattorossi A, Benedetti Panici P, Mancuso S (1997) Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis. Br J Cancer 75:884–891CrossRefGoogle Scholar
  57. 57.
    Shen F, Xue X, Weber G (1999) Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res 19:1657–1662Google Scholar
  58. 58.
    McDougal A, Wormke M, Calvin J, Safe S (2001) Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. Cancer Res 61:3902–3907Google Scholar
  59. 59.
    Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour G, Zhang L, Lu M, Weinberg O, Rao JY, Brooks MN (2006) The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27:2424–2433CrossRefGoogle Scholar
  60. 60.
    Mense SM, Chhabra J, Bhat HK (2008) Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin. J Steroid Biochem Mol Biol 110:157–162CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Carlota Oleaga
    • 1
  • Miriam García
    • 1
  • Anna Solé
    • 1
  • Carlos J. Ciudad
    • 1
  • Maria Izquierdo-Pulido
    • 2
  • Véronique Noé
    • 1
    Email author
  1. 1.Department of Biochemistry and Molecular BiologySchool of Pharmacy, University of BarcelonaBarcelonaSpain
  2. 2.Department of Nutrition and Food ScienceSchool of Pharmacy, University of BarcelonaBarcelonaSpain

Personalised recommendations